6197 — Solasto Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Solasto, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	106,182	117,239	131,088	135,139	137,435
Cost of Revenue
Gross Profit	18,861	20,464	21,753	21,934	22,401
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	100,843	111,778	126,092	131,045	130,690
Operating Profit	5,339	5,461	4,996	4,094	6,745
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,354	5,641	5,418	4,141	6,454
Provision for Income Taxes
Net Income After Taxes	3,539	3,503	3,173	2,257	3,961
Net Income Before Extraordinary Items
Net Income	3,539	3,503	3,173	2,257	3,961
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,538	3,502	3,172	2,257	3,960
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	56.1	57.4	60.1	51.8	62.7
Dividends per Share